Published in Am J Respir Crit Care Med on November 05, 2009
Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34
Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax (2010) 1.80
Methods in comparative effectiveness research. J Clin Oncol (2012) 1.12
The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms. Cancer Res Treat (2011) 0.99
Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer (2012) 0.91
The role of stereotactic body radiation therapy (SBRT) in the treatment of oligometastatic disease in the elderly. Br J Radiol (2015) 0.86
Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.80
Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J (2012) 0.79
Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer. AJR Am J Roentgenol (2013) 0.78
Update in lung cancer and oncological disorders 2010. Am J Respir Crit Care Med (2011) 0.78
Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. J Thorac Oncol (2015) 0.75
Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancer. Onco Targets Ther (2015) 0.75
Optimal therapy for elderly patients with early stage non-small cell lung cancer. Am J Respir Crit Care Med (2010) 0.75
SBRT in operable early stage lung cancer patients. Transl Lung Cancer Res (2014) 0.75
A systematic review of instrumental variable analyses using geographic region as an instrument. Cancer Epidemiol (2017) 0.75
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med (2002) 24.87
Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65
Development of a comorbidity index using physician claims data. J Clin Epidemiol (2000) 19.31
Why we need observational studies to evaluate the effectiveness of health care. BMJ (1996) 17.27
Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68
Racial differences in the treatment of early-stage lung cancer. N Engl J Med (1999) 9.65
Multidisciplinary management of lung cancer. N Engl J Med (2004) 7.13
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol (2007) 4.81
Studying radiation therapy using SEER-Medicare-linked data. Med Care (2002) 4.13
Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Serv Res (1998) 2.50
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol (2001) 2.37
Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys (1992) 2.30
The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer (2003) 1.96
Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1993) 1.95
Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol (2003) 1.94
Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol (1999) 1.86
Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1988) 1.83
Econometric approaches to epidemiologic data: relating endogeneity and unobserved heterogeneity to confounding. Ann Epidemiol (1997) 1.72
Lung cancer--where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med (2002) 1.54
Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol (1988) 1.43
Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest (2005) 1.37
Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol (2007) 1.28
The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest (1995) 1.24
Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.14
Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.11
The role of curative radiotherapy in the treatment of lung cancer. Cancer (1980) 1.09
Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys (1996) 0.97
Curative radiotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys (1990) 0.96
Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer (1999) 0.94
Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol (2003) 0.94
High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer (2001) 0.92
Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiother Oncol (1997) 0.91
Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol (1989) 0.89
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1990) 0.82
Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1997) 0.82
Reassessment of radiation therapy for the management of lung cancer in patients with chronic pulmonary disease. Int J Radiat Oncol Biol Phys (1983) 0.82
Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 0.82
Radiotherapy alone for patients with operable carcinoma of the lung. Chest (1985) 0.80
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med (2012) 3.15
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol (2014) 2.57
Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation (2011) 2.30
Tying up loose ends: discharging patients with unresolved medical issues. Arch Intern Med (2007) 2.15
Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA (2012) 2.06
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation (2011) 1.91
Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med (2010) 1.57
Distribution of febrile seizure duration and associations with development. Ann Neurol (2011) 1.47
The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery. Dermatol Surg (2003) 1.39
PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION. Endocr Pract (2016) 1.39
Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med (2010) 1.38
Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest (2005) 1.37
Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis (2007) 1.34
Claims about religious involvement and health outcomes. Ann Behav Med (2002) 1.32
Hostility, interpersonal interactions, and ambulatory blood pressure. Psychosom Med (2003) 1.30
Design and phenomenology of the FEBSTAT study. Epilepsia (2012) 1.28
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery (2011) 1.14
Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med (2011) 1.09
Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City. Epilepsia (2008) 1.06
Physical activity and right ventricular structure and function. The MESA-Right Ventricle Study. Am J Respir Crit Care Med (2010) 1.05
The effect of aerobic training and cardiac autonomic regulation in young adults. Am J Public Health (2009) 1.04
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma. Cancer (2003) 1.03
Prevalence of self-reported epilepsy in a multiracial and multiethnic community in New York City. Epilepsy Res (2007) 1.02
Morbidity and mortality in type B Niemann-Pick disease. Genet Med (2013) 1.00
Design and implementation of clinical trials in rehabilitation research. Arch Phys Med Rehabil (2012) 0.98
Sociodemographic correlates of stage of adoption for colorectal cancer screening in African Americans. Ethn Dis (2009) 0.96
Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers (2010) 0.96
Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Dev Psychobiol (2003) 0.94
Comparative anatomy of chromosomal domains with imprinted and non-imprinted allele-specific DNA methylation. PLoS Genet (2013) 0.93
Deriving heart period variability from blood pressure waveforms. J Appl Physiol (1985) (2003) 0.92
Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer (2012) 0.91
Effects of maternal breathing rate, psychiatric status, and cortisol on fetal heart rate. Dev Psychobiol (2010) 0.91
Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol (2011) 0.90
Elucidating the relationship between negative affectivity and symptoms: the role of illness-specific affective responses. Ann Behav Med (2007) 0.90
Early trajectory of psychiatric symptoms after traumatic brain injury: relationship to patient and injury characteristics. J Neurotrauma (2014) 0.89
Intronic locus determines SHROOM3 expression and potentiates renal allograft fibrosis. J Clin Invest (2014) 0.89
Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc (2014) 0.88
Role of TAP-1 and/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol (2004) 0.88
Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol (2009) 0.88
Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. Int J Cardiol (2013) 0.88
Risk factors for venous thromboembolism after lung transplantation. Chest (2007) 0.88
Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 0.87
Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives. Lung Cancer (2011) 0.86
Medical complications during inpatient rehabilitation among patients with traumatic disorders of consciousness. Arch Phys Med Rehabil (2013) 0.86
Risk factors for febrile status epilepticus: a case-control study. J Pediatr (2013) 0.85
An evidence-based domestic violence education program for internal medicine residents. Teach Learn Med (2003) 0.84
Patients with newly diagnosed multiple myeloma and chromosome 1 amplification have poor outcomes despite the use of novel triplet regimens. Am J Hematol (2014) 0.84
Impact of aerobic training on cardiovascular reactivity to and recovery from challenge. Psychosom Med (2011) 0.83
Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemp Clin Trials (2010) 0.81
Effect of radiotherapy planning complexity on survival of elderly patients with unresected localized lung cancer. Int J Radiat Oncol Biol Phys (2010) 0.80
The renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study. Pulm Circ (2012) 0.80
Rifaximin diminishes neutropenia following potentially lethal whole-body radiation. Exp Biol Med (Maywood) (2010) 0.80
Cardiac autonomic control and treatment of hostility: a randomized controlled trial. Psychosom Med (2009) 0.80
A comparative evaluation of existing grading scales in intracerebral hemorrhage. Neurocrit Care (2011) 0.79
Radiotherapy and chemotherapy for elderly patients with stage I-II unresected lung cancer. Eur Respir J (2012) 0.79
Factors associated with time to follow-up of severe hyperkalemia in the ambulatory setting. Am J Med Qual (2007) 0.79
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Ann Am Thorac Soc (2015) 0.79
Brachial artery diameter and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-right ventricle study. Chest (2012) 0.79
Complement Factor H Y402H polymorphism is associated with an increased risk of mortality after intracerebral hemorrhage. J Clin Neurosci (2011) 0.78
Association of patient-provider communication domains with lung cancer treatment. J Thorac Oncol (2014) 0.77
Underlying cause of death in incident unprovoked seizures in the urban community of Northern Manhattan, New York City. Epilepsia (2009) 0.77
Investigation of familial aggregation of seizures in neurocysticercosis patients. Epilepsy Res (2009) 0.77
Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer. Lung Cancer (2013) 0.77
Effects of marketed antiepileptic drugs and placebo in the human photosensitivity screening protocol. Neurotherapeutics (2014) 0.77
Seizure in people with newly diagnosed active or transitional neurocysticercosis. Seizure (2010) 0.77
New approach to the statistical analysis of cardiovascular data. J Appl Physiol (1985) (2005) 0.76
The association of living conditions and lifestyle factors with burden of cysts among neurocysticercosis patients in Ecuador. Trans R Soc Trop Med Hyg (2012) 0.76
Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer. Am J Clin Oncol (2015) 0.75
Brain O2. J Neurosurg (2006) 0.75
The literature on religion and health: caveat emptor. J Pastoral Care Counsel (2004) 0.75
Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy. Am J Clin Oncol (2016) 0.75
Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection. Ann Am Thorac Soc (2013) 0.75
Soft Tissue Adjuncts in Revisionary Aesthetic Breast Surgery. Ann Plast Surg (2017) 0.75
Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Brachytherapy (2002) 0.75
Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment. Ann Surg Oncol (2014) 0.75